|
|
| | Rontalizumab Basic information |
| Product Name: | Rontalizumab | | Synonyms: | Rontalizumab;Research Grade Rontalizumab;Rontalizumab (anti-IFNA1) | | CAS: | 948570-30-7 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Rontalizumab Structure]() |
| | Rontalizumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Rontalizumab Usage And Synthesis |
| Uses | Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1]. | | References | [1] McBride JM, et al. Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. Arthritis Rheum. 2012 Nov;64(11):3666-76. DOI:10.1002/art.34632 |
| | Rontalizumab Preparation Products And Raw materials |
|